Glycogen Storage Disease Type I: What to Do When Dietary Management Fails to Maintain Blood Glucose
Preventing hypoglycaemia is the central challenge in glycogen storage disease type I. When first-line dietary management does not sustain blood glucose at or above the target threshold or fails to prevent rapid glucose swings, a structured next-line protocol provides an additional intervention to stabilise glucose availability.
Previous line — targets not achieved
The first-line strategy — avoidance of fasting with small, frequent feedings high in complex carbohydrates distributed evenly over 24 hours, restriction of sucrose, fructose, and galactose, and supplementation with a complete multivitamin, calcium, and vitamin D — did not maintain blood glucose at 70 mg/dl or higher or adequately prevent rapid glucose fluctuations. This protocol represents the next therapeutic step.
Next-line approach — partial overview
The next-line regimen involves an oral slow-release carbohydrate supplement administered at timed intervals and prepared in a specifically restricted fluid — with the interval and amount varying by age group. The complete dosing schedule, weight-based quantities, timing windows, and preparation requirements are contained in the full protocol.
Treatment goals
Maintain blood glucose above 70 mg/dl and lactate below 2 mmol/l.
References
DOI: 10.1038/gim.2014.128
- Raw cornstarch (CS) has been used for the treatment of hypoglycemia in GSD I since the early 1980s.
- General guidelines for dosing CS include 1.6 g of CS per kilogram of body weight (ideal body weight) every 3–4 hours for young children, and 1.7–2.5 g CS/kg every 4–5 hours (sometimes 6 hours) for older children, adolescents, and adults.
- Some adults may eventually only require one dose of CS at bedtime to maintain their BG at more than 70 mg/dl or 4 mmol/l and to maintain their lactates at less than 2 mmol/l through the night.
View source ↗